O'Shaughnessy Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,474	Closed	-$266K	–	2636
2025 Q3	$266K	Buy	+12,474	New	+$295K	﹤0.01%	1812
2021 Q4	–	Sell	-261	Closed	-$4K	–	1261
2021 Q3	$4K	Hold	261	–	–	﹤0.01%	2357
2021 Q2	$6K	Hold	261	–	–	﹤0.01%	2094
2021 Q1	$7K	Hold	261	–	–	﹤0.01%	1841
2020 Q4	$14K	Hold	261	–	–	﹤0.01%	1474
2020 Q3	$11K	Hold	261	–	–	﹤0.01%	1328
2020 Q2	$13K	Buy	+261	New	+$12.5K	﹤0.01%	1206
2020 Q1	–	Sell	-355	Closed	-$15K	–	1270
2019 Q4	$15K	Buy	+355	New	+$15.4K	﹤0.01%	1199

Other funds holding ACAD

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return